We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
Comply with good pharmacovigilance practice and prepare for an inspection.
An independent piece of research on ‘trigger points’ for switching suppliers in regulated markets whether in banking, energy or telecoms.
Urgent public health message on coronavirus (COVID-19) hospitalised cases who have travelled from China in the preceding 14 days.
Information for healthcare professionals on how pulse oximeters are regulated, home use and issues to look out for when using the devices
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Information for healthcare professionals to protect the public from pressure ulcers (bed sores).
This national report provides insights into the care experienced by cancer patients across England who were treated as day cases or inpatients during the first three months of 2010.
Interim guidance to support NHS Trusts in managing the de-isolation and discharge of mpox-infected patients.
The Environment Agency has published the findings of an investigation into appropriate indicators of soil quality for the UK.
Paper prepared by the University of Edinburgh on optimising trigger times for social distancing measures.
Screening tool to help identify individuals who may need a referral for a full assessment of eligibility for NHS continuing healthcare.
Information for patients who have an unpaid debt for NHS care.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Government outlines action to make UK a world leader in tackling ethnic and other biases in medical devices.
A literature review and meta-analysis of individual patient data
Clinical supervisors should complete this form to request the discharge of a restricted patient.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine ganaxolone (Ztalmy) as the first anti-seizure medication in the UK to treat cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD).
Form T135: Social circumstances report: Supplementary information required for patients under the age of 18.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.